Company:Benitec Biopharma

From HandWiki
Revision as of 21:34, 9 February 2024 by Nautica (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Benitec Biopharma Ltd
TypeBiotechnology
NASDAQBNTC
IndustryRNA interference
Founded1997
HeadquartersMelbourne, Victoria, Australia
Key people
Michael Graham (Founding Scientist & Head of Discovery)
ProductsGene silencing, Gene expression, RNA interference (ddRNAi)
Websitewww.benitec.com

Benitec Biopharma Limited (ASXBLT) is an Australian biotechnology company founded in 1997.[1] It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference (ddRNAi) technology.[2]

The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research.[3]


Research and development

Benitec Biopharma is researching ddRNAi in the following fields:

References

External links